US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 1.000
  • -0.020-1.96%
Close Sep 6 16:00 ET
73.54MMarket Cap-5555P/E (TTM)

Protalix Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-172.59%-3.61M
239.69%4.19M
94.73%-1.32M
237.69%3.6M
25.16%-6.89M
167.60%4.97M
48.57%-3M
-143.07%-25M
48.67%-2.61M
-389.57%-9.2M
Net income from continuing operations
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
48.08%-1.85M
462.56%19.34M
-36.96%-3.13M
45.88%-14.93M
43.90%-3.74M
15.05%-3.57M
Operating gains losses
109.09%1K
-75.00%5K
92.96%-38K
139.35%61K
-325.00%-108K
97.88%-11K
-76.47%20K
-166.42%-540K
-2,037.50%-155K
-94.30%48K
Depreciation and amortization
8.87%319K
15.00%322K
9.67%1.19M
13.82%313K
11.72%305K
9.33%293K
3.70%280K
-2.86%1.09M
6.18%275K
-4.21%273K
Deferred tax
97.80%-69K
---138K
---3.09M
--0
--38K
---3.13M
--0
--0
--0
----
Other non cash items
-21.74%-504K
-4,181.82%-471K
12.92%-600K
-27.06%124K
-464.15%-299K
39.39%-414K
91.06%-11K
-122.30%-689K
-57.82%170K
-106.02%-53K
Change In working capital
81.36%-2.15M
1,251.57%8.08M
12.28%-10.54M
2,491.33%7.77M
4.08%-6.07M
-738.20%-11.54M
84.78%-702K
-221.35%-12.02M
-39.02%300K
-2,420.72%-6.33M
-Change in receivables
-90.44%-7.05M
-54.33%1.75M
64.15%-428K
-16.41%3.76M
25.33%-4.31M
-254.98%-3.7M
265.21%3.82M
-15.70%-1.19M
47.81%4.5M
-131.83%-5.77M
-Change in inventory
143.56%1.63M
5.66%-3.3M
-294.87%-2.24M
213.20%2.54M
-200.15%-1.95M
667.82%668K
-357.28%-3.5M
123.60%1.15M
30.46%-2.24M
278.44%1.95M
-Change in payables and accrued expense
-50.97%1.61M
-500.57%-1.41M
210.22%5.3M
503.01%1.48M
-58.45%177K
185.39%3.29M
134.92%353K
-301.43%-4.8M
-127.83%-366K
-73.61%426K
-Change in other current assets
200.00%6K
55.56%14K
360.00%13K
-96.00%1K
133.33%9K
---6K
--9K
-102.07%-5K
-65.75%25K
-136.49%-27K
-Change in other current liabilities
----
----
--0
----
----
----
----
--0
----
----
-Change in other working capital
114.05%1.66M
895.32%11.04M
-84.00%-13.18M
--0
--0
-589,600.00%-11.79M
47.54%-1.39M
-154.13%-7.16M
-125.87%-1.62M
-273.11%-2.9M
Cash from discontinued investing activities
Operating cash flow
-172.59%-3.61M
239.69%4.19M
94.73%-1.32M
237.69%3.6M
25.16%-6.89M
167.60%4.97M
48.57%-3M
-143.07%-25M
48.67%-2.61M
-389.57%-9.2M
Investing cash flow
Cash flow from continuing investing activities
18.92%-180K
-112.81%-606K
-231.90%-16.71M
-106.90%-342K
-453.16%-20.88M
-162.18%-222K
129.11%4.73M
-126.61%-5.04M
-86.77%4.95M
27.72%5.91M
Net PPE purchase and sale
15.69%-172K
-141.13%-598K
-82.96%-1.15M
-17.37%-250K
-670.69%-447K
-59.38%-204K
-8.30%-248K
55.33%-628K
52.46%-213K
83.14%-58K
Net investment purchase and sale
----
----
-208.40%-15.42M
--0
-440.33%-20.42M
--0
131.25%5M
-125.00%-5M
-86.78%5M
20.00%6M
Net other investing changes
55.56%-8K
60.00%-8K
-123.95%-142K
-155.42%-92K
60.00%-12K
-103.71%-18K
28.57%-20K
81.35%593K
238.78%166K
-11.11%-30K
Cash from discontinued investing activities
Investing cash flow
18.92%-180K
-112.81%-606K
-231.90%-16.71M
-106.90%-342K
-453.16%-20.88M
-162.18%-222K
129.11%4.73M
-126.61%-5.04M
-86.77%4.95M
27.72%5.91M
Financing cash flow
Cash flow from continuing financing activities
0
0
199.42%24.67M
0
0
10.43M
14.23M
-31.79%8.24M
200.72%4.08M
105.85%1.52M
Net issuance payments of debt
----
----
--0
----
----
----
----
--0
----
----
Net common stock issuance
--0
--0
190.85%23.95M
--0
--0
--9.72M
--14.23M
-82.17%8.24M
--4.08M
--1.52M
Proceeds from stock option exercised by employees
----
----
35,500.00%712K
--0
--0
----
----
--2K
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
199.42%24.67M
--0
--0
294.74%10.43M
--14.23M
-31.79%8.24M
200.72%4.08M
105.85%1.52M
Net cash flow
Beginning cash position
-17.64%27.21M
38.12%23.63M
-56.11%17.11M
90.37%20.41M
285.72%48.18M
95.62%33.04M
-56.11%17.11M
113.44%38.99M
0.73%10.72M
-63.13%12.49M
Current changes in cash
-124.96%-3.79M
-77.57%3.58M
130.45%6.64M
-49.31%3.25M
-1,466.99%-27.77M
448.58%15.18M
172.29%15.97M
-205.23%-21.8M
-77.33%6.42M
92.38%-1.77M
Effect of exchange rate changes
44.44%-20K
83.33%-7K
-48.05%-114K
-3.85%-27K
---9K
10.00%-36K
-281.82%-42K
-1,383.33%-77K
-165.00%-26K
--0
End cash Position
-51.44%23.4M
-17.64%27.21M
38.12%23.63M
38.12%23.63M
90.37%20.41M
285.72%48.18M
95.62%33.04M
-56.11%17.11M
-56.11%17.11M
0.73%10.72M
Free cash flow
-179.30%-3.78M
210.60%3.59M
90.37%-2.47M
218.45%3.35M
20.81%-7.34M
163.72%4.77M
46.42%-3.25M
-118.22%-25.63M
48.98%-2.82M
-316.46%-9.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -172.59%-3.61M239.69%4.19M94.73%-1.32M237.69%3.6M25.16%-6.89M167.60%4.97M48.57%-3M-143.07%-25M48.67%-2.61M-389.57%-9.2M
Net income from continuing operations -111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M48.08%-1.85M462.56%19.34M-36.96%-3.13M45.88%-14.93M43.90%-3.74M15.05%-3.57M
Operating gains losses 109.09%1K-75.00%5K92.96%-38K139.35%61K-325.00%-108K97.88%-11K-76.47%20K-166.42%-540K-2,037.50%-155K-94.30%48K
Depreciation and amortization 8.87%319K15.00%322K9.67%1.19M13.82%313K11.72%305K9.33%293K3.70%280K-2.86%1.09M6.18%275K-4.21%273K
Deferred tax 97.80%-69K---138K---3.09M--0--38K---3.13M--0--0--0----
Other non cash items -21.74%-504K-4,181.82%-471K12.92%-600K-27.06%124K-464.15%-299K39.39%-414K91.06%-11K-122.30%-689K-57.82%170K-106.02%-53K
Change In working capital 81.36%-2.15M1,251.57%8.08M12.28%-10.54M2,491.33%7.77M4.08%-6.07M-738.20%-11.54M84.78%-702K-221.35%-12.02M-39.02%300K-2,420.72%-6.33M
-Change in receivables -90.44%-7.05M-54.33%1.75M64.15%-428K-16.41%3.76M25.33%-4.31M-254.98%-3.7M265.21%3.82M-15.70%-1.19M47.81%4.5M-131.83%-5.77M
-Change in inventory 143.56%1.63M5.66%-3.3M-294.87%-2.24M213.20%2.54M-200.15%-1.95M667.82%668K-357.28%-3.5M123.60%1.15M30.46%-2.24M278.44%1.95M
-Change in payables and accrued expense -50.97%1.61M-500.57%-1.41M210.22%5.3M503.01%1.48M-58.45%177K185.39%3.29M134.92%353K-301.43%-4.8M-127.83%-366K-73.61%426K
-Change in other current assets 200.00%6K55.56%14K360.00%13K-96.00%1K133.33%9K---6K--9K-102.07%-5K-65.75%25K-136.49%-27K
-Change in other current liabilities ----------0------------------0--------
-Change in other working capital 114.05%1.66M895.32%11.04M-84.00%-13.18M--0--0-589,600.00%-11.79M47.54%-1.39M-154.13%-7.16M-125.87%-1.62M-273.11%-2.9M
Cash from discontinued investing activities
Operating cash flow -172.59%-3.61M239.69%4.19M94.73%-1.32M237.69%3.6M25.16%-6.89M167.60%4.97M48.57%-3M-143.07%-25M48.67%-2.61M-389.57%-9.2M
Investing cash flow
Cash flow from continuing investing activities 18.92%-180K-112.81%-606K-231.90%-16.71M-106.90%-342K-453.16%-20.88M-162.18%-222K129.11%4.73M-126.61%-5.04M-86.77%4.95M27.72%5.91M
Net PPE purchase and sale 15.69%-172K-141.13%-598K-82.96%-1.15M-17.37%-250K-670.69%-447K-59.38%-204K-8.30%-248K55.33%-628K52.46%-213K83.14%-58K
Net investment purchase and sale ---------208.40%-15.42M--0-440.33%-20.42M--0131.25%5M-125.00%-5M-86.78%5M20.00%6M
Net other investing changes 55.56%-8K60.00%-8K-123.95%-142K-155.42%-92K60.00%-12K-103.71%-18K28.57%-20K81.35%593K238.78%166K-11.11%-30K
Cash from discontinued investing activities
Investing cash flow 18.92%-180K-112.81%-606K-231.90%-16.71M-106.90%-342K-453.16%-20.88M-162.18%-222K129.11%4.73M-126.61%-5.04M-86.77%4.95M27.72%5.91M
Financing cash flow
Cash flow from continuing financing activities 00199.42%24.67M0010.43M14.23M-31.79%8.24M200.72%4.08M105.85%1.52M
Net issuance payments of debt ----------0------------------0--------
Net common stock issuance --0--0190.85%23.95M--0--0--9.72M--14.23M-82.17%8.24M--4.08M--1.52M
Proceeds from stock option exercised by employees --------35,500.00%712K--0--0----------2K--0--0
Cash from discontinued financing activities
Financing cash flow --0--0199.42%24.67M--0--0294.74%10.43M--14.23M-31.79%8.24M200.72%4.08M105.85%1.52M
Net cash flow
Beginning cash position -17.64%27.21M38.12%23.63M-56.11%17.11M90.37%20.41M285.72%48.18M95.62%33.04M-56.11%17.11M113.44%38.99M0.73%10.72M-63.13%12.49M
Current changes in cash -124.96%-3.79M-77.57%3.58M130.45%6.64M-49.31%3.25M-1,466.99%-27.77M448.58%15.18M172.29%15.97M-205.23%-21.8M-77.33%6.42M92.38%-1.77M
Effect of exchange rate changes 44.44%-20K83.33%-7K-48.05%-114K-3.85%-27K---9K10.00%-36K-281.82%-42K-1,383.33%-77K-165.00%-26K--0
End cash Position -51.44%23.4M-17.64%27.21M38.12%23.63M38.12%23.63M90.37%20.41M285.72%48.18M95.62%33.04M-56.11%17.11M-56.11%17.11M0.73%10.72M
Free cash flow -179.30%-3.78M210.60%3.59M90.37%-2.47M218.45%3.35M20.81%-7.34M163.72%4.77M46.42%-3.25M-118.22%-25.63M48.98%-2.82M-316.46%-9.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg